Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/30067
Title: Multidisciplinary therapy, respiratory and nutritional support for patients with motor neuron disease
Authors: Georgiou, Anastasios M. 
Major Field of Science: Medical and Health Sciences
Field Category: Health Sciences
Keywords: Health;Health science
Issue Date: 26-Jun-2020
Source: Disability: Functional Diversity, 2020, pp. 107 - 120
Start page: 107
End page: 120
Abstract: Motor neuron disease (MND) is a fatal progressive neurological condition. Riluzole is the only pharmacological agent that is currently prescribed for all MND types. It is suggested that a 100 mg daily dose is safe and probably prolongs median survival by about 2-3 months in patients with MND. Multidisciplinary team treatment can help relieve symptoms, improve quality of life (QoL) and increase survival rates in patients suffering from this condition. As respiratory, nutritional and swallowing problems are amongst the most important factors associated with decreased QoL and shorter survival, a large and growing body of literature has been investigating respiratory and nutritional support in MND care
URI: https://hdl.handle.net/20.500.14279/30067
ISBN: 978-153617967-5
ISSN: 978-153617966-8
Rights: © Nova Science Publishers
Attribution-NonCommercial-NoDerivatives 4.0 International
Type: Book
Affiliation : Cyprus University of Technology 
Publication Type: Peer Reviewed
Appears in Collections:Κεφάλαια βιβλίων/Book chapters

CORE Recommender
Show full item record

Page view(s)

154
Last Week
1
Last month
8
checked on Dec 21, 2024

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons